메뉴 건너뛰기
Rheumatology
Volumn 50, Issue 12, 2011, Pages 2311-2313
BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis

(15)  Bukhari, Marwan a   Abernethy, Rikki b   Deighton, Chris c   Ding, Tina c   Hyrich, Kimme d   Lunt, Mark d   Luqmani, Raashid e   Kiely, Patrick f   Bosworth, Ailsa g   Ledingham, Jo h   Östör, Andrew i   Gadsby, Kate a   McKenna, Frank j   Finney, Diana k   Dixey, Josh l  

Author keywords

Eligibility; Guideline; Rheumatoid arthritis; Rituximab; Safety
Indexed keywords

ADALIMUMAB; CD4 ANTIGEN; CD8 ANTIGEN; ETANERCEPT; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; INFLIXIMAB; RITUXIMAB; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;
EID: 82355161712     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ker106a     Document Type: Note
Times cited : (37)
References (5)
  • 1
    • 77953512883 scopus 로고    scopus 로고
    • BSR and BHPR rheumatoid arthritis guidelines on eligibility for the first biological therapy
    • Deighton C, Hyrich K, Ding T et al. BSR and BHPR rheumatoid arthritis guidelines on eligibility for the first biological therapy. Rheumatology 2010;49:1197-9.
    • (2010) Rheumatology , vol.49 , pp. 1197-1199
    • Deighton, C.1    Hyrich, K.2    Ding, T.3
  • 2
    • 78649381672 scopus 로고    scopus 로고
    • BSR and BHPR rheumatoid arthritis guidelines on safety of anti TNF therapies
    • Ding T, Ledingham J, Luqmani R et al. BSR and BHPR rheumatoid arthritis guidelines on safety of anti TNF therapies. Rheumatology 2010;49:2217-9.
    • (2010) Rheumatology , vol.49 , pp. 2217-2219
    • Ding, T.1    Ledingham, J.2    Luqmani, R.3
  • 3
    • 84856313062 scopus 로고    scopus 로고
    • Rituximab for the treatment of rheumatoid arthritis (refractory). National Institute of Health and Clinical Excellence. (August, date last accessed)
    • Rituximab for the treatment of rheumatoid arthritis (refractory). National Institute of Health and Clinical Excellence. http://www.nice.org.uk/Guidance/TA126 (August 2010, date last accessed).
    • (2010)
  • 4
    • 33846877022 scopus 로고    scopus 로고
    • Consensus statement on the use of rituximab in patients with rheumatoid arthritis
    • Smolen JS, Keystone EC, Emery P et al. Consensus statement on the use of rituximab in patients with rheumatoid arthritis. Ann Rheum Dis 2007;66:143-50.
    • (2007) Ann Rheum Dis , vol.66 , pp. 143-150
    • Smolen, J.S.1    Keystone, E.C.2    Emery, P.3
  • 5
    • 2942537697 scopus 로고    scopus 로고
    • Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
    • Edwards JC, Szczepanski L, Szechinski J et al. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 2004;350: 2572-81.
    • (2004) N Engl J Med , vol.350 , pp. 2572-2581
    • Edwards, J.C.1    Szczepanski, L.2    Szechinski, J.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.